
News & Articles
Home / About Barrow Neurological Institute / Archives for Barrow Media Relations
Author: Barrow Media Relations
Barrow Surgeon Treats Essential Tremor with Focused Ultrasound
- Patient Stories
- Byline: Barrow Media Relations
- May 22, 2023
After more than a decade of living with a neurological disorder that causes involuntary and rhythmic shaking, an Arizona man has been relieved of his symptoms thanks to...
Study: Common Gout Medication Reduces Risk of Alzheimer’s, Parkinson’s, ALS
- Press Releases
- Byline: Barrow Media Relations
- May 17, 2023
A groundbreaking national study co-authored by a Barrow Neurological Institute neurologist and researcher has found a common gout medication reduced risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic...
FDA Grants Approval of New Drug Therapy to Slow the Progression of ALS
- Press Releases
- Byline: Barrow Media Relations
- April 26, 2023
Phoenix’s Barrow Neurological Institute Instrumental in Studies that Led to Today’s FDA Approval A leading amyotrophic lateral sclerosis (ALS) neurologist at Barrow Neurological Institute played an important role...
Top Seven of Seven Series – 2022
- Uncategorized
- Byline: Barrow Media Relations
- March 20, 2023
While Dr. Lawton takes hiatus a from operating this week to enjoy some spring break skiing, we will be counting down the top seven episodes of Seven Series...
State of Mind: A Special Letter From the President and CEO
- In the News
- Byline: Barrow Media Relations
- January 19, 2023
For many of us, a new year is a time for reflections and resolutions. As President and CEO of Barrow Neurological Institute, I’ve been thinking about my first...